These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1994550)

  • 1. Evidence that the fate of class II-disparate corneal grafts is determined by the timing of class II expression.
    Ross J; Callanan D; Kunz H; Niederkorn J
    Transplantation; 1991 Feb; 51(2):532-6. PubMed ID: 1994550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class I disparate corneal grafts enjoy afferent but not efferent blockade of the immune response.
    Ross J; He YG; Niederkorn JY
    Curr Eye Res; 1991 Sep; 10(9):889-92. PubMed ID: 1790719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The differential effects of donor versus host Langerhans cells in the rejection of MHC-matched corneal allografts.
    Ross J; He YG; Pidherney M; Mellon J; Niederkorn JY
    Transplantation; 1991 Nov; 52(5):857-61. PubMed ID: 1949172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of donor Langerhans cells on corneal graft rejection.
    Niederkorn JY; Ross JR; He Y
    J Invest Dermatol; 1992 Nov; 99(5):104S-106S. PubMed ID: 1431197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptance of H-Y-disparate corneal grafts despite concomitant immunization of the recipient.
    He YG; Ross J; Callanan D; Niederkorn JY
    Transplantation; 1991 Jun; 51(6):1258-62. PubMed ID: 2048199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunogenic privilege of corneal allografts.
    Niederkorn JY; Peeler JS; Ross J; Callanan D
    Reg Immunol; 1989; 2(2):117-24. PubMed ID: 2701814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative contribution of major histocompatibility complex antigens to the immunogenicity of corneal allografts.
    Treseler PA; Sanfilippo F
    Transplantation; 1986 Apr; 41(4):508-14. PubMed ID: 3515652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute rejection of orthotopic corneal xenografts in mice depends on CD4(+) T cells and self-antigen-presenting cells.
    Tanaka K; Sonoda K; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2878-84. PubMed ID: 11687532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of class II antigen-expressing cells in corneal allograft immunity.
    Gebhardt BM
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2254-60. PubMed ID: 2242991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-MHC antigens and their relative resistance to immunosuppression after corneal transplantation.
    Nicholls SM; Bradley BA; Easty DL
    Eye (Lond); 1995; 9 ( Pt 2)():208-14. PubMed ID: 7556719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of major and minor histocompatibility antigens in orthotopic corneal transplantation in mice.
    Hasková Z; Filipec M; Holán V
    Folia Biol (Praha); 1996; 42(3):105-11. PubMed ID: 8971221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice.
    Hori J; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):720-6. PubMed ID: 11222533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orthotopic corneal transplantation in mice--evidence that the immunogenetic rules of rejection do not apply.
    Sonoda Y; Streilein JW
    Transplantation; 1992 Oct; 54(4):694-704. PubMed ID: 1412761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
    Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S
    Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pure class II MHC disparity does not induce rejection of cornea or heart grafts in the rat.
    Katami M; Lim SM; Kamada N; Davies HF; Butcher GW; White DJ; Watson PG; Calne RY
    Transplant Proc; 1990 Oct; 22(5):2200-1. PubMed ID: 2219343
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of cytokine-induced migration of Langerhans cells on corneal allograft survival.
    Niederkorn JY
    Eye (Lond); 1995; 9 ( Pt 2)():215-8. PubMed ID: 7556720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.